Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care
NCT ID: NCT00161668
Last Updated: 2007-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2001-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia
NCT01548911
A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-World
NCT04337138
Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant
NCT00044733
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
NCT00860639
Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia
NCT01869803
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
DEFINED_POPULATION
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mylotarg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Provide ICF
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Monitor
Role: STUDY_DIRECTOR
Wyeth is now a wholly owned subsidiary of Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tucson, Arizona, United States
Berkely, California, United States
Burbank, California, United States
Concord, California, United States
Loma Linda, California, United States
Los Angeles, California, United States
San Francisco, California, United States
Sylmar, California, United States
Denver, Colorado, United States
Boynton Beach, Florida, United States
Plantation, Florida, United States
Stuart, Florida, United States
Tamarac, Florida, United States
Chicago, Illinois, United States
Chicago, Illinois, United States
Chicago, Illinois, United States
Chicago, Illinois, United States
Indianapolis, Indiana, United States
Iowa City, Iowa, United States
Lexington, Kentucky, United States
Louisville, Kentucky, United States
Shrevport, Louisiana, United States
Ann Arbor, Michigan, United States
Grand Rapids, Michigan, United States
Kalamazoo, Michigan, United States
Kalamazoo, Michigan, United States
Columbia, Missouri, United States
St Louis, Missouri, United States
Neptune City, New Jersey, United States
Albuquerque, New Mexico, United States
Buffalo, New York, United States
New Hyde Park, New York, United States
New York, New York, United States
New York, New York, United States
The Bronx, New York, United States
Valhalla, New York, United States
Durham, North Carolina, United States
Winston-Salem, North Carolina, United States
Bismarck, North Dakota, United States
Akron, Ohio, United States
Canton, Ohio, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Oklahoma City, Oklahoma, United States
Portland, Oregon, United States
Hershey, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Memphis, Tennessee, United States
Nashville, Tennessee, United States
Nashville, Tennessee, United States
Houston, Texas, United States
Temple, Texas, United States
Arlington, Virginia, United States
Richmond, Virginia, United States
Charleston, West Virginia, United States
Morgantown, West Virginia, United States
Appleton, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0903X-100847
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.